LifeCell Corp (NASDAQ:LIFC.DL)
CAPS Rating:
The Company develops and markets tissue-based products for use in reconstructive, orthopedic and urogynecologic surgical procedures to repair soft tissue defects.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
No players have picked LIFC.DL yet. Tell us why you think LIFC.DL will outperform or underperform the market.
RSS Headlines
Fool UK
